Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hereditary leiomyomatosis and renal cell cancer × Temozolomide × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 20 Glioma 11 Brain Neoplasms 7 Sarcoma, Ewing 6 Gliosarcoma 6 Astrocytoma 6 Rhabdomyosarcoma 3 Recurrence 3 Neoplasm Metastasis 3 Medulloblastoma 3 Ependymoma 3 Diffuse Intrinsic Pontine Glioma 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Osteosarcoma 2 Neuroblastoma 2 Lymphoma, Follicular 2 Lymphoma 2 Colorectal Neoplasms 2 Wilms Tumor 1 Somatostatinoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1

Interventions

spartalizumab 1 atezolizumab 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Everolimus 1 Erlotinib Hydrochloride 1 Disulfides 1 Contrast Media 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡